RLEFX
Price
$34.35
Change
+$0.05 (+0.15%)
Updated
May 8 closing price
Net Assets
234.05B
SFAAX
Price
$37.58
Change
+$0.06 (+0.16%)
Updated
May 8 closing price
Net Assets
1.21B
Ad is loading...

RLEFX vs SFAAX

Header iconRLEFX vs SFAAX Comparison
Open Charts RLEFX vs SFAAXBanner chart's image
American Funds American Balanced R5E
Price$34.35
Change+$0.05 (+0.15%)
VolumeN/A
Net Assets234.05B
Allspring Index Asset Allocation A
Price$37.58
Change+$0.06 (+0.16%)
VolumeN/A
Net Assets1.21B
RLEFX vs SFAAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RLEFX vs. SFAAX commentary
May 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RLEFX is a Buy and SFAAX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RLEFX has more cash in the bank: 234B vs. SFAAX (1.21B). RLEFX pays higher dividends than SFAAX: RLEFX (2.17) vs SFAAX (1.02). RLEFX was incepted earlier than SFAAX: RLEFX (9 years) vs SFAAX (39 years). SFAAX (1.11) is less costly to investors than RLEFX (0.39). RLEFX is a more actively managed with annual turnover of: 44.00 vs. SFAAX (12.00). RLEFX has a lower initial minimum investment than SFAAX: RLEFX (250) vs SFAAX (1000). RLEFX annual gain was more profitable for investors over the last year : 4.93 vs. SFAAX (-3.73). RLEFX return over 5 years is better than : 37.87 vs. SFAAX (8.06).
RLEFXSFAAXRLEFX / SFAAX
Total Expense Ratio0.391.0736%
Annual Report Gross Expense Ratio0.391.1135%
Fund Existence9 years39 years-
Gain YTD0.504-2.411-21%
Front LoadN/A6%-
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets234B1.21B19,355%
Annual Yield % from dividends2.171.02213%
Returns for 1 year4.93-3.73-132%
Returns for 3 years22.441.271,763%
Returns for 5 years37.878.06470%
Returns for 10 yearsN/A31.16-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
STOK9.050.39
+4.50%
Stoke Therapeutics
STVN22.480.68
+3.12%
Stevanato Group SpA
AMBP3.620.08
+2.26%
Ardagh Metal Packaging SA
XBIT2.850.06
+2.15%
XBiotech
CHSCL25.56-0.14
-0.54%
CHS